A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO)
Phase of Trial: Phase IV
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms MAESTRO
- 11 Jul 2017 Planned End Date changed from 1 May 2017 to 1 May 2018.
- 11 Jul 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 08 Jun 2017 Results (n=31) presented at the 21st International Congress of Parkinson's Disease and Movement Disorders.